KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Short-term Investments (2016 - 2026)

Biogen has reported Short-term Investments over the past 17 years, most recently at $900.0 million for Q1 2026.

  • For Q1 2026, Short-term Investments changed N/A year-over-year to $900.0 million; the TTM value through Mar 2026 reached $900.0 million, changed N/A, while the annual FY2025 figure was $807.2 million, N/A changed from the prior year.
  • Short-term Investments for Q1 2026 was $900.0 million at Biogen, up from $807.2 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $3.5 billion in Q2 2023 and troughed at $97.6 million in Q3 2025.
  • A 4-year average of $1.6 billion and a median of $1.5 billion in 2022 define the central range for Short-term Investments.
  • On a YoY basis, Short-term Investments climbed as much as 64.37% in 2022 and fell as far as 12.58% in 2022.
  • Year by year, Short-term Investments stood at $1.5 billion in 2022, then skyrocketed by 134.85% to $3.5 billion in 2023, then tumbled by 76.67% to $807.2 million in 2025, then increased by 11.5% to $900.0 million in 2026.
  • Business Quant data shows Short-term Investments for BIIB at $900.0 million in Q1 2026, $807.2 million in Q4 2025, and $97.6 million in Q3 2025.